What is AbCellera Biologics Inc.'s capital treatment of items?

AbCellera Biologics Inc. (ABCL) reported capital treatment of items of $551.25K in Q4 2024.

What does capital treatment of items mean?

This refers to the specific tax treatment applied to capital gains or losses, which are often taxed at different rates than ordinary operating income. It identifies the portion of the tax reconciliation attributable to investment activities rather than core business operations. This metric helps investors understand the tax implications of the company's capital allocation strategy.

AbCellera Biologics Inc. ABCL Capital treatment of items

Capital treatment of items at other companies

BeldenBDC

$13.06M—

Ralliant CorporationRAL

$40.7M-58.7%

Corebridge FinancialCRBG

$0—

Service Properties TrustSVC

0%—

Jefferies Financial GroupJEF

$0-100%

KKR & Co.KKR

$96.48M+6.4%

Other financials

Income statement

See full

Revenue$8.3M+96.3%

Operating income-$57.5M+8.2%

Net income-$43.2M+5.4%

EPS (diluted)-$0.14+6.7%

Balance sheet

See full

Cash & equivalents$102.1M-44.6%

Total debt$140.2M+107%

Total equity$938.1M-8.3%

Total assets$1.3B-2.8%

Cash flow

See full

Operating cash flow-$33.5M-190%

CapEx$3.8M-64.0%

Free cash flow-$37.4M-68.3%

Valuation

See full

Market cap$1.84B+59.2%

Enterprise value$1.88B+100.0%

P/S23.3×-26.8×

Profitability

See full

Operating margin-267.6%-120pp

Net margin-181.7%-77.9pp

FCF margin-238.9%-90.9pp

Returns & leverage

See full

Return on equity-14.7%-0.8pp

Debt / equity0.1×+0.1×

Current ratio14.1×+3.9×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept abcl:EffectiveIncomeTaxRateReconciliationCapitalTreatmentAmount.

The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s capital treatment of items.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AbCellera Biologics Inc.'s capital treatment of items?: AbCellera Biologics Inc. (ABCL) reported capital treatment of items of $551.25K in Q4 2024.
What does capital treatment of items mean?: This refers to the specific tax treatment applied to capital gains or losses, which are often taxed at different rates than ordinary operating income. It identifies the portion of the tax reconciliation attributable to investment activities rather than core business operations. This metric helps investors understand the tax implications of the company's capital allocation strategy.